Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder

The outcome of node positive or metastatic urothelial carcinoma of the bladder (mUCB) is poor and palliative chemotherapy has long been considered the only treatment option for this patient group. Cytoreduction and metastasis-directed therapy, either by surgery or radiotherapy, has been successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Decaestecker, Karel, Fonteyne, Valérie, Oosterlinck, Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760372/
https://www.ncbi.nlm.nih.gov/pubmed/29354498
http://dx.doi.org/10.21037/tau.2017.08.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760372/
https://www.ncbi.nlm.nih.gov/pubmed/29354498
http://dx.doi.org/10.21037/tau.2017.08.09

Ejemplares similares